Related references
Note: Only part of the references are listed.Leflunomide for chronic musculoskeletal graft versus host disease following allogeneic hematopoietic stem cell transplant
Sachin Punatar et al.
BONE MARROW TRANSPLANTATION (2020)
Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial
Yiwen Wang et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells
Li Cheng et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
COVID-19 in teriflunomide-treated patients with multiple sclerosis
Amir Hadi Maghzi et al.
JOURNAL OF NEUROLOGY (2020)
Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer
Brock A. Humphries et al.
BREAST CANCER RESEARCH (2020)
Leflunomide Synergizes with Gemcitabine in Growth Inhibition of PC Cells and Impairs c-Myc Signaling through PIM Kinase Targeting
Ralf Buettner et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis
Yao Huang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Leflunomide-induced liver injury in mice: Involvement of TLR4 mediated activation of PI3K/mTOR/NFκB pathway
Rabie E. Elshaer et al.
LIFE SCIENCES (2019)
Anti-arthritic effect of β-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats
Sawsan M. A. El-Sheikh et al.
LIFE SCIENCES (2019)
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
Chao Liang et al.
NATURE COMMUNICATIONS (2019)
Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial
Minfang Zhang et al.
CLINICAL RHEUMATOLOGY (2019)
Dihydroorotate dehydrogenase inhibitors in anti-infective drug research
Donatella Boschi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cyclophosphamide-induced severe acute hepatitis in a rheumatic disease: case-based review
Dondu Uskudar Cansu et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting
Ralf Buettner et al.
BLOOD ADVANCES (2019)
Leflunomide: A promising drug with good antitumor potential
Chunying Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Antiviral activity of A771726, the active metabolite of leflunomide, against Junin virus
Claudia S. Sepulveda et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Mitochondrial dysfunction induced by leflunomide and its active metabolite
Jiekun Xuan et al.
TOXICOLOGY (2018)
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
Maolin Chu et al.
SCIENTIFIC REPORTS (2018)
Teriflunomide Is an Indirect Human Constitutive Androstane Receptor (CAR) Activator Interacting With Epidermal Growth Factor (EGF) Signaling
Alejandro Carazo et al.
FRONTIERS IN PHARMACOLOGY (2018)
Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity
Bjoern Ambrosius et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells
Zhen Ren et al.
TOXICOLOGY (2017)
Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells
Satoshi Imanishi et al.
ONCOTARGET (2017)
Inhibition of p70 S6 kinase (S6K1) activity by A77 1726, the active metabolite of leflunomide, induces autophagy through TAK1-mediated AMPK and JNK activation
Xiulong Xu et al.
ONCOTARGET (2017)
Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
Andrea Bilger et al.
ONCOTARGET (2017)
A case of lymphoma in a patient on teriflunomide treatment for relapsing multiple sclerosis
Anne Landais et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Lilian Aly et al.
CURRENT NEUROPHARMACOLOGY (2017)
Antiviral treatment of BK virus viremia after kidney transplantation
Andrew D. Santeusanio et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2017)
Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells
A. K. Mohamad Fairus et al.
BIOCHIMIE (2017)
Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy: A Case Report and Review of the Literature
Melissa Laub et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2016)
Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia
David B. Sykes et al.
CELL (2016)
Assessment of the Therapeutic Effect of Total Glucosides of Peony for Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis
Yongsong Cai et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Aqueous extract from Aconitum carmichaelii Debeaux reduces liver injury in rats via regulation of HMGB1/TLR4/NF-KB/caspase-3 and PCNA signaling pathways
Jian-Xing Luo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
The protective effect of total phenolics from Oenanthe Javanica on acute liver failure induced by D-galactosamine
Guo Ai et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Detection of in Vitro Metabolite Formation of Leflunomide: A Fluorescence Dynamics and Electronic Structure Study
Poornima Sharma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
AMPK Activation Prevents and Reverses Drug-Induced Mitochondrial and Hepatocyte Injury by Promoting Mitochondrial Fusion and Function
Sun Woo Sophie Kang et al.
PLOS ONE (2016)
As2O3 combined with leflunomide prolongs heart xenograft survival via suppressing the response of Th1, Th2, and B cells in a rat model
Zhi-Xing Jiao et al.
XENOTRANSPLANTATION (2016)
Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells
Yicheng Chen et al.
ONCOTARGET (2016)
Chemopreventive effect of leflunomide against Ehrlich's solid tumor grown in mice: Effect on EGF and EGFR expression and tumor proliferation
Hoda I. Bahr et al.
LIFE SCIENCES (2015)
Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis
Shymaa E. Bilasy et al.
PHARMACOLOGICAL REPORTS (2015)
Effect of Rheum palmatum L. on NF- κ B signaling pathway of mice with acute liver failure
Rong-Zhen Zhang et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2015)
1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats
H. Wang et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Evaluation of mechanism of hepatotoxicity of leflunomide using albino wistar rats
Lal Lodhi
African Journal of Pharmacy and Pharmacology (2014)
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
Amit Bar-Or
EXPERIMENTAL NEUROLOGY (2014)
Inhibition of p70 S6 Kinase (S6K1) Activity by A77 1726 and Its Effect on Cell Proliferation and Cell Cycle Progress
Michelle E. Doscas et al.
NEOPLASIA (2014)
Leflunomide suppresses growth in human medullary thyroid cancer cells
Amal Alhefdhi et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation
Young H. Jung et al.
PEDIATRIC TRANSPLANTATION (2013)
Leflunomide Reduces Proliferation and Induces Apoptosis in Neuroblastoma Cells In Vitro and In Vivo
Shunqin Zhu et al.
PLOS ONE (2013)
Efficacy and Safety of Nonbiologic Immunosuppressants in the Treatment of Nonrenal Systemic Lupus Erythematosus: A Systematic Review
Jose M. Pego-Reigosa et al.
ARTHRITIS CARE & RESEARCH (2013)
Therapeutic effect of leflunomide on the development of experimental lupus nephritis in mice
Chunyan He et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Combined use of rapamycin and leflunomide in prevention of acute cardiac allografts rejection in rats
Yan Sun et al.
TRANSPLANT IMMUNOLOGY (2012)
Leflunomide for cytomegalovirus: bench to bedside
B. Chacko et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis
Xiao-Yong Zheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Akt and mTOR in B cell activation and differentiation
Jose J. Limon et al.
FRONTIERS IN IMMUNOLOGY (2012)
Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide
Melinda C. Cox Dunn et al.
ANTIVIRAL THERAPY (2011)
Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients
Rachna Gupta et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2011)
Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options
Giuseppe Pignataro et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Inhibiting effects of Leflunomide metabolite on overexpression of CD147, MMP-2 and MMP-9 in PMA differentiated THP-1 cells
Jian-lin Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Hepatotoxicity related to antirheumatic drugs
Guruprasad P. Aithal
NATURE REVIEWS RHEUMATOLOGY (2011)
Toxicidade hepática é rara em pacientes com artrite reumatoide usando terapia combinada de leflunomida e metotrexato
Jorge Augusto Nunes Rodrigues Alves et al.
Revista Brasileira De Reumatologia (2011)
Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide
J. R. Curtis et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Leflunomide Inhibition of BK Virus Replication in Renal Tubular Epithelial Cells
Eva Bernhoff et al.
JOURNAL OF VIROLOGY (2010)
The Effect of Leflunomide on Cycling and Activation of T-Cells in HIV-1-Infected Participants
Sarah W. Read et al.
PLOS ONE (2010)
The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor
Edmond F. O'Donnell et al.
PLOS ONE (2010)
Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients
Carlos E. Araya et al.
PEDIATRIC TRANSPLANTATION (2010)
Teriflunomide (Leflunomide) Promotes Cytostatic, Antioxidant, and Apoptotic Effects in Transformed Prostate Epithelial Cells: Evidence Supporting a Role for Teriflunomide in Prostate Cancer Chemoprevention
Numsen Hail et al.
NEOPLASIA (2010)
Drug-induced liver injury: Is it somehow foreseeable?
Giovanni Tarantino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Is Leflunomide Effective in the Treatment of Psoriasis in a Patient Who Is Unable to Benefit From Standard First- and Second-Line Therapies and Needs an Affordable Treatment Option?
Andrew Graeme Affleck et al.
ARCHIVES OF DERMATOLOGY (2008)
Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients
Petra Bohanec Grabar et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Chemosensitizing anti-cancer activity of LFM-A13, a leflunomide metabolite analog targeting polo-like kinases
Fatih M. Uckun
CELL CYCLE (2007)
Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells
Norifumi Sawamukai et al.
JOURNAL OF IMMUNOLOGY (2007)
Teratogenicity study of the dihydroorotate-dehydrogenase inhibitor and protein tyrosine kinase inhibitor Leflunomide in mice
Ryou Fukushima et al.
REPRODUCTIVE TOXICOLOGY (2007)
Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation
Stanislas Faguer et al.
TRANSPLANT INTERNATIONAL (2007)
Antivirals for the treatment of polyomavirus BK replication
Christine Hanssen Rinaldo et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Leflunomide or A77 1726 protect from acetaminophen-induced cell injury through inhibition of JNK-mediated mitochondrial permeability transition in immortalized human hepatocytes
Calivarathan Latchoumycandane et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Low dose leflunomide activates PI3K/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents
D. Y. Leger et al.
APOPTOSIS (2006)
Polyomavirus-associated nephropathy: update on antiviral strategies
M. A. Josephson et al.
TRANSPLANT INFECTIOUS DISEASE (2006)
Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients
M. Cutolo et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide
K. Ehlert et al.
KLINISCHE PADIATRIE (2006)
Concurrent antiviral and immunosuppressive activities of leflunomide in vivo
AS Chong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy
Nurullah Akkoc et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2006)
Idiosyncratic drug hepatotoxicity
N Kaplowitz
NATURE REVIEWS DRUG DISCOVERY (2005)
CMV-infected allogeneic endothelial cells initiate responder and bystander donor HLA class I release via the metalloproteinase cleavage pathway
LD Haynes et al.
HUMAN IMMUNOLOGY (2005)
Post-coronary artery bypass graft liver failure: A possible association with leflunomide
SC Thomasset et al.
ANNALS OF THORACIC SURGERY (2005)
Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats
HS Zeng et al.
TRANSPLANTATION (2005)
Mast cells in inflammatory arthritis
PA Nigrovic et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Leflunomide in the treatment of rheumatoid arthritis
EK Li et al.
CLINICAL THERAPEUTICS (2004)
Leflunomide for the treatment of rheumatoid arthritis in clinical practice - Incidence and severity of hepatotoxicity
EN van Roon et al.
DRUG SAFETY (2004)
Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor κB
M Imose et al.
HEPATOLOGY (2004)
Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus
LS Tam et al.
LUPUS (2004)
Leflunomide-induced acute hepatitis
C Sevilla-Mantilla et al.
DIGESTIVE AND LIVER DISEASE (2004)
Leflunomide use during the first 33 months after food and drug administration approval: Experience with a national cohort of 3,325 patients
C Siva et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
In vitro metabolism studies on the isoxazole ring scission in the anti-inflammatory agent leflunomide to its active α-cyanoenol metabolite A771726:: Mechanistic similarities with the cytochrome P450-catalyzed dehydration of aldoximes
AS Kalgutkar et al.
DRUG METABOLISM AND DISPOSITION (2003)
Effect of leflunomide on immunological liver injury in mice
HW Yao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Mechanism of leflunomide-induced proliferation of mitochondria in mammalian cells
JH Spodnik et al.
MITOCHONDRION (2002)
Fatal hepatitis with leflunomide and itraconazole
A Legras et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide
DA Knight et al.
TRANSPLANTATION (2001)
Leflunomide: mode of action in the treatment of rheumatoid arthritis
FC Breedveld et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Share Paper
